Literature DB >> 27928666

Utility of double endoscopic intraluminal operation for esophageal cancer.

Makoto Sohda1, Hideyuki Saito2, Tomonori Yoshida2, Yuji Kumakura2, Hiroaki Honjyo2, Keigo Hara2, Daigo Ozawa2, Shigemasa Suzuki2, Naritaka Tanaka2, Makoto Sakai2, Tatsuya Miyazaki2, Minoru Fukuchi2, Hiroyuki Kuwano2.   

Abstract

OBJECTIVES: Endoscopic submucosal dissection (ESD) is a more difficult technique for esophageal cancer than for gastric cancer because the working space for esophageal ESD is small. Further, the difficulty level gradually increases depending on the size of the carcinoma. To overcome these difficulties, double endoscopic intraluminal operation (DEILO), which enables the resection of mucosal lesions using two fine endoscopes and monopolar shears, was reported previously. Here, we report the utility of DEILO for esophageal cancer.
METHODS: A total of 26 esophageal cancer patients (19 men and seven women) with 26 lesions treated using DEILO between 2011 and 2014 at Gunma University Hospital were included. We evaluated the utility and safety of DEILO for early esophageal cancer.
RESULTS: For all patients (100%), the DEILO procedure was performed successfully, and en bloc resection was achieved. The median operation time, postoperative hospital stay, and the longitudinal dimension of resected specimens were 123 min (range 45-236 min), 5 days, and 32 mm, respectively. Perioperative perforation, pneumothorax, and mediastinal emphysema were not recognized. Only one patient was diagnosed with a postoperative hemorrhage, but the bleeding was successfully treated by bleeding vessel coagulation.
CONCLUSION: DEILO has good utility as a technique of ESD for early esophageal cancers. Additional improvement and advancement of the procedure will increase the indication of DEILO.

Entities:  

Keywords:  DEILO; ESD; Esophageal cancer

Mesh:

Year:  2016        PMID: 27928666     DOI: 10.1007/s00464-016-5368-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  15 in total

Review 1.  Application of regenerative medical technology using tissue-engineered cell sheets for endoscopic submucosal dissection of esophageal neoplasms.

Authors:  Takeshi Ohki; Masayuki Yamato; Masaho Ota; Ryo Takagi; Makoto Kondo; Nobuo Kanai; Teruo Okano; Masakazu Yamamoto
Journal:  Dig Endosc       Date:  2014-10-28       Impact factor: 7.559

2.  Outcomes of patients with early gastric cancer who underwent double endoscopic intraluminal surgery.

Authors:  Yoshitaka Toyomasu; Masaki Suzuki; Toru Yanoma; Akiharu Kimura; Norimichi Kogure; Kyoichi Ogata; Tetsuro Ohno; Erito Mochiki; Hiroyuki Kuwano
Journal:  Surg Endosc       Date:  2015-04-01       Impact factor: 4.584

3.  Endoscopic submucosal dissection of early esophageal cancer.

Authors:  Tsuneo Oyama; Akihisa Tomori; Kinichi Hotta; Syuko Morita; Ken Kominato; Masaki Tanaka; Yoshinori Miyata
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

4.  Endoscopic submucosal dissection of esophageal squamous cell neoplasms.

Authors:  Mitsuhiro Fujishiro; Naohisa Yahagi; Naomi Kakushima; Shinya Kodashima; Yosuke Muraki; Satoshi Ono; Nobutake Yamamichi; Ayako Tateishi; Yasuhito Shimizu; Masashi Oka; Keiji Ogura; Takao Kawabe; Masao Ichinose; Masao Omata
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-19       Impact factor: 11.382

5.  Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan.

Authors:  Ryu Ishihara; Hiroyasu Iishi; Noriya Uedo; Yoji Takeuchi; Sachiko Yamamoto; Takuya Yamada; Eriko Masuda; Koji Higashino; Motohiko Kato; Hiroyuki Narahara; Masaharu Tatsuta
Journal:  Gastrointest Endosc       Date:  2008-07-11       Impact factor: 9.427

6.  Usefulness of clip traction in the early phase of esophageal endoscopic submucosal dissection.

Authors:  Masaho Ota; Tsutomu Nakamura; Kazuhiko Hayashi; Takeshi Ohki; Kousuke Narumiya; Takuya Sato; Yuji Shirai; Kenji Kudo; Masakazu Yamamoto
Journal:  Dig Endosc       Date:  2012-04-02       Impact factor: 7.559

Review 7.  Oesophageal cancer treatment: studies, strategies and facts.

Authors:  A Wobst; R A Audisio; M Colleoni; J G Geraghty
Journal:  Ann Oncol       Date:  1998-09       Impact factor: 32.976

8.  Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.

Authors:  Hajime Isomoto; Naoyuki Yamaguchi; Toshiyuki Nakayama; Tomayoshi Hayashi; Hitoshi Nishiyama; Ken Ohnita; Fuminao Takeshima; Saburo Shikuwa; Shigeru Kohno; Kazuhiko Nakao
Journal:  BMC Gastroenterol       Date:  2011-05-04       Impact factor: 3.067

9.  A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection.

Authors:  Hiroaki Takahashi; Yoshiaki Arimura; Satoshi Okahara; Junichi Kodaira; Kaku Hokari; Hiroyuki Tsukagoshi; Yasuhisa Shinomura; Masao Hosokawa
Journal:  BMC Gastroenterol       Date:  2015-01-22       Impact factor: 3.067

10.  Effect of endoscopic submucosal dissection for superficial esophageal neoplasms and risk factors for postoperative stricture.

Authors:  Keita Funakawa; Hirofumi Uto; Fumisato Sasaki; Yuichiro Nasu; Seiichi Mawatari; Shiho Arima; Junichi Nakazawa; Hiroki Taguchi; Shinichi Hashimoto; Shuji Kanmura; Hitoshi Setoyama; Masatsugu Numata; Hirohito Tsubouchi; Akio Ido
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

View more
  2 in total

1.  Comparable Data Between Double Endoscopic Intraluminal Operation and Conventional Endoscopic Submucosal Dissection for Esophageal Cancer.

Authors:  Makoto Sohda; Kengo Kuriyama; Tomonori Yoshida; Yuji Kumakura; Hiroaki Honjo; Makoto Sakai; Tatsuya Miyazaki; Hiroyuki Kuwano
Journal:  J Gastrointest Surg       Date:  2019-02-13       Impact factor: 3.452

2.  Resection of Mucosal and Submucosal Gastrointestinal Lesions and a Double Endoscope Experience.

Authors:  Şükrü Çolak; Bünyamin Gürbulak; Ekrem Çakar; Hasan Bektaş
Journal:  JSLS       Date:  2019 Jan-Mar       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.